The long-term outcome of patients with hypertensive cardiomyopathy
The prognosis of dilated cardiomyopathy due to hypertension (HT-DCM) is surprisingly unknown, particularly in the absence of coronary disease and diabetes. We aimed at investigating the long-term outcome and the predictors of mortality in patients with left ventricular systolic dysfunction exclusive...
Gespeichert in:
| Veröffentlicht in: | Journal of human hypertension 2005-05, Vol.19 (5), p.393-400 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 400 |
|---|---|
| container_issue | 5 |
| container_start_page | 393 |
| container_title | Journal of human hypertension |
| container_volume | 19 |
| creator | de Carvalho Frimm, C Soufen, H N Koike, M K Pereira, V F A Cúri, M |
| description | The prognosis of dilated cardiomyopathy due to hypertension (HT-DCM) is surprisingly unknown, particularly in the absence of coronary disease and diabetes. We aimed at investigating the long-term outcome and the predictors of mortality in patients with left ventricular systolic dysfunction exclusively due to hypertension. From October 1995 to May 2001, 90 consecutive patients with echocardiographic fractional shortening (FS) |
| doi_str_mv | 10.1038/sj.jhh.1001836 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_67757812</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A183330769</galeid><sourcerecordid>A183330769</sourcerecordid><originalsourceid>FETCH-LOGICAL-c556t-c7013c2b3608eb928d5c745fe5a532bf120807bafba47297cf772e5b9f7757683</originalsourceid><addsrcrecordid>eNp1kk1v3CAQhlHVqtmmvfZYWa2SmzeADdjHNEo_pEi9pGeE2WGNZcMWcKr998WKpW2rRBwGzTzzzjAMQu8J3hJcNVdx2A59n--YNBV_gTakFrxkjIqXaINbhsuW1vgMvYlxyEwONq_RGWGC8LYhG_T5vodi9G5fJghT4eek_QSFN8VBJQsuxeK3TX3RHw8QErhoH6DQKuysn44-M_3xLXpl1Bjh3WrP0c8vt_c338q7H1-_31zflZoxnkotMKk07SqOG-ha2uyYFjUzwBSraGcIxQ0WnTKdqgVthTZCUGBdmy3LbVfn6PJR9xD8rxlikpONGsZROfBzlHzhGkIz-Ok_cPBzcLk3SXmNmagxXaiPz1KkbTmvKT5J7dUI0jrjU1B6qSuv88CrCgveZmr7BJXPDiarvQNjs_-fhMu_EnpQY-qjH-dkvYtPKuvgYwxg5CHYSYWjJFguCyDjIPMCyHUBcsKH9VVzN8HuhK8_noGLFVBRq9EE5bSNJ44LSghbKl89cjGH3B7CaTzPlP4Duv_FIA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219966420</pqid></control><display><type>article</type><title>The long-term outcome of patients with hypertensive cardiomyopathy</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>SpringerLink Journals - AutoHoldings</source><creator>de Carvalho Frimm, C ; Soufen, H N ; Koike, M K ; Pereira, V F A ; Cúri, M</creator><creatorcontrib>de Carvalho Frimm, C ; Soufen, H N ; Koike, M K ; Pereira, V F A ; Cúri, M</creatorcontrib><description>The prognosis of dilated cardiomyopathy due to hypertension (HT-DCM) is surprisingly unknown, particularly in the absence of coronary disease and diabetes. We aimed at investigating the long-term outcome and the predictors of mortality in patients with left ventricular systolic dysfunction exclusively due to hypertension. From October 1995 to May 2001, 90 consecutive patients with echocardiographic fractional shortening (FS) <30% and 29 control patients with FS ⩾30% were included. Obstructive coronary disease was excluded by dipyridamole myocardial perfusion imaging in all patients and coronary angiography in 60. After a mean follow-up of 4.3±1.6 years, the total mortality rate of HT-DCM was twice as much higher than that of patients without left ventricular systolic dysfunction (
P
=0.01). In HT-DCM, the 5-year mortality rate was 26%. Univariate analyses selected age and creatinine for being positively related to mortality, and body mass index, FS and blood pressure during follow-up for being negatively related to mortality. Neither the improvement of left ventricular FS nor the decrease in left ventricular mass index was related to survival. Multivariate analysis identified (hazard ratio; 95% confidence interval) age (1.08; 1.02–1.13), body mass index (0.86; 0.75–0.98), and baseline FS (0.88; 0.78–0.98) as independent predictors of mortality. In conclusion, poor survival in HT-DCM can be anticipated by the severity of left ventricular systolic dysfunction and advanced age. Instead of ominous signs, high blood pressure and body mass may predict a more favourable prognosis.</description><identifier>ISSN: 0950-9240</identifier><identifier>EISSN: 1476-5527</identifier><identifier>DOI: 10.1038/sj.jhh.1001836</identifier><identifier>PMID: 15716981</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Age ; Angiography ; Antihypertensive agents ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Blood pressure ; Blood Pressure - physiology ; Body Mass Index ; Cardiology. Vascular system ; Cardiomyopathy ; Cardiomyopathy, Dilated - etiology ; Cardiomyopathy, Dilated - mortality ; Cardiomyopathy, Dilated - physiopathology ; Cardiovascular system ; Care and treatment ; Clinical manifestations. Epidemiology. Investigative techniques. Etiology ; Coronary Angiography ; Creatinine ; Diabetes mellitus ; Diagnosis ; Dilated cardiomyopathy ; Dipyridamole ; Echocardiography ; Epidemiology ; Female ; Follow-Up Studies ; Health Administration ; Heart ; Heart diseases ; Heart Ventricles - diagnostic imaging ; Heart Ventricles - physiopathology ; Humans ; Hypertension ; Hypertension - complications ; Hypertension - diagnosis ; Hypertension - physiopathology ; Male ; Medical prognosis ; Medical sciences ; Medicine ; Medicine & Public Health ; Middle Aged ; Mortality ; Multivariate analysis ; Myocardial Contraction - physiology ; original-article ; Perfusion ; Pharmacology. Drug treatments ; Physiological aspects ; Predictive Value of Tests ; Prognosis ; Public Health ; Retrospective Studies ; Risk factors ; Severity of Illness Index ; Survival Rate - trends ; Time Factors ; Ventricle ; Ventricular Dysfunction, Left - complications ; Ventricular Dysfunction, Left - diagnosis ; Ventricular Dysfunction, Left - physiopathology</subject><ispartof>Journal of human hypertension, 2005-05, Vol.19 (5), p.393-400</ispartof><rights>Springer Nature Limited 2005</rights><rights>2005 INIST-CNRS</rights><rights>COPYRIGHT 2005 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group May 2005</rights><rights>Nature Publishing Group 2005.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c556t-c7013c2b3608eb928d5c745fe5a532bf120807bafba47297cf772e5b9f7757683</citedby><cites>FETCH-LOGICAL-c556t-c7013c2b3608eb928d5c745fe5a532bf120807bafba47297cf772e5b9f7757683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/sj.jhh.1001836$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/sj.jhh.1001836$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16721159$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15716981$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Carvalho Frimm, C</creatorcontrib><creatorcontrib>Soufen, H N</creatorcontrib><creatorcontrib>Koike, M K</creatorcontrib><creatorcontrib>Pereira, V F A</creatorcontrib><creatorcontrib>Cúri, M</creatorcontrib><title>The long-term outcome of patients with hypertensive cardiomyopathy</title><title>Journal of human hypertension</title><addtitle>J Hum Hypertens</addtitle><addtitle>J Hum Hypertens</addtitle><description>The prognosis of dilated cardiomyopathy due to hypertension (HT-DCM) is surprisingly unknown, particularly in the absence of coronary disease and diabetes. We aimed at investigating the long-term outcome and the predictors of mortality in patients with left ventricular systolic dysfunction exclusively due to hypertension. From October 1995 to May 2001, 90 consecutive patients with echocardiographic fractional shortening (FS) <30% and 29 control patients with FS ⩾30% were included. Obstructive coronary disease was excluded by dipyridamole myocardial perfusion imaging in all patients and coronary angiography in 60. After a mean follow-up of 4.3±1.6 years, the total mortality rate of HT-DCM was twice as much higher than that of patients without left ventricular systolic dysfunction (
P
=0.01). In HT-DCM, the 5-year mortality rate was 26%. Univariate analyses selected age and creatinine for being positively related to mortality, and body mass index, FS and blood pressure during follow-up for being negatively related to mortality. Neither the improvement of left ventricular FS nor the decrease in left ventricular mass index was related to survival. Multivariate analysis identified (hazard ratio; 95% confidence interval) age (1.08; 1.02–1.13), body mass index (0.86; 0.75–0.98), and baseline FS (0.88; 0.78–0.98) as independent predictors of mortality. In conclusion, poor survival in HT-DCM can be anticipated by the severity of left ventricular systolic dysfunction and advanced age. Instead of ominous signs, high blood pressure and body mass may predict a more favourable prognosis.</description><subject>Age</subject><subject>Angiography</subject><subject>Antihypertensive agents</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood pressure</subject><subject>Blood Pressure - physiology</subject><subject>Body Mass Index</subject><subject>Cardiology. Vascular system</subject><subject>Cardiomyopathy</subject><subject>Cardiomyopathy, Dilated - etiology</subject><subject>Cardiomyopathy, Dilated - mortality</subject><subject>Cardiomyopathy, Dilated - physiopathology</subject><subject>Cardiovascular system</subject><subject>Care and treatment</subject><subject>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</subject><subject>Coronary Angiography</subject><subject>Creatinine</subject><subject>Diabetes mellitus</subject><subject>Diagnosis</subject><subject>Dilated cardiomyopathy</subject><subject>Dipyridamole</subject><subject>Echocardiography</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Health Administration</subject><subject>Heart</subject><subject>Heart diseases</subject><subject>Heart Ventricles - diagnostic imaging</subject><subject>Heart Ventricles - physiopathology</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - complications</subject><subject>Hypertension - diagnosis</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Multivariate analysis</subject><subject>Myocardial Contraction - physiology</subject><subject>original-article</subject><subject>Perfusion</subject><subject>Pharmacology. Drug treatments</subject><subject>Physiological aspects</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Public Health</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Severity of Illness Index</subject><subject>Survival Rate - trends</subject><subject>Time Factors</subject><subject>Ventricle</subject><subject>Ventricular Dysfunction, Left - complications</subject><subject>Ventricular Dysfunction, Left - diagnosis</subject><subject>Ventricular Dysfunction, Left - physiopathology</subject><issn>0950-9240</issn><issn>1476-5527</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kk1v3CAQhlHVqtmmvfZYWa2SmzeADdjHNEo_pEi9pGeE2WGNZcMWcKr998WKpW2rRBwGzTzzzjAMQu8J3hJcNVdx2A59n--YNBV_gTakFrxkjIqXaINbhsuW1vgMvYlxyEwONq_RGWGC8LYhG_T5vodi9G5fJghT4eek_QSFN8VBJQsuxeK3TX3RHw8QErhoH6DQKuysn44-M_3xLXpl1Bjh3WrP0c8vt_c338q7H1-_31zflZoxnkotMKk07SqOG-ha2uyYFjUzwBSraGcIxQ0WnTKdqgVthTZCUGBdmy3LbVfn6PJR9xD8rxlikpONGsZROfBzlHzhGkIz-Ok_cPBzcLk3SXmNmagxXaiPz1KkbTmvKT5J7dUI0jrjU1B6qSuv88CrCgveZmr7BJXPDiarvQNjs_-fhMu_EnpQY-qjH-dkvYtPKuvgYwxg5CHYSYWjJFguCyDjIPMCyHUBcsKH9VVzN8HuhK8_noGLFVBRq9EE5bSNJ44LSghbKl89cjGH3B7CaTzPlP4Duv_FIA</recordid><startdate>20050501</startdate><enddate>20050501</enddate><creator>de Carvalho Frimm, C</creator><creator>Soufen, H N</creator><creator>Koike, M K</creator><creator>Pereira, V F A</creator><creator>Cúri, M</creator><general>Nature Publishing Group UK</general><general>Nature Publishing</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20050501</creationdate><title>The long-term outcome of patients with hypertensive cardiomyopathy</title><author>de Carvalho Frimm, C ; Soufen, H N ; Koike, M K ; Pereira, V F A ; Cúri, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c556t-c7013c2b3608eb928d5c745fe5a532bf120807bafba47297cf772e5b9f7757683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Age</topic><topic>Angiography</topic><topic>Antihypertensive agents</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood pressure</topic><topic>Blood Pressure - physiology</topic><topic>Body Mass Index</topic><topic>Cardiology. Vascular system</topic><topic>Cardiomyopathy</topic><topic>Cardiomyopathy, Dilated - etiology</topic><topic>Cardiomyopathy, Dilated - mortality</topic><topic>Cardiomyopathy, Dilated - physiopathology</topic><topic>Cardiovascular system</topic><topic>Care and treatment</topic><topic>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</topic><topic>Coronary Angiography</topic><topic>Creatinine</topic><topic>Diabetes mellitus</topic><topic>Diagnosis</topic><topic>Dilated cardiomyopathy</topic><topic>Dipyridamole</topic><topic>Echocardiography</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Health Administration</topic><topic>Heart</topic><topic>Heart diseases</topic><topic>Heart Ventricles - diagnostic imaging</topic><topic>Heart Ventricles - physiopathology</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - complications</topic><topic>Hypertension - diagnosis</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Multivariate analysis</topic><topic>Myocardial Contraction - physiology</topic><topic>original-article</topic><topic>Perfusion</topic><topic>Pharmacology. Drug treatments</topic><topic>Physiological aspects</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Public Health</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Severity of Illness Index</topic><topic>Survival Rate - trends</topic><topic>Time Factors</topic><topic>Ventricle</topic><topic>Ventricular Dysfunction, Left - complications</topic><topic>Ventricular Dysfunction, Left - diagnosis</topic><topic>Ventricular Dysfunction, Left - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Carvalho Frimm, C</creatorcontrib><creatorcontrib>Soufen, H N</creatorcontrib><creatorcontrib>Koike, M K</creatorcontrib><creatorcontrib>Pereira, V F A</creatorcontrib><creatorcontrib>Cúri, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of human hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Carvalho Frimm, C</au><au>Soufen, H N</au><au>Koike, M K</au><au>Pereira, V F A</au><au>Cúri, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The long-term outcome of patients with hypertensive cardiomyopathy</atitle><jtitle>Journal of human hypertension</jtitle><stitle>J Hum Hypertens</stitle><addtitle>J Hum Hypertens</addtitle><date>2005-05-01</date><risdate>2005</risdate><volume>19</volume><issue>5</issue><spage>393</spage><epage>400</epage><pages>393-400</pages><issn>0950-9240</issn><eissn>1476-5527</eissn><abstract>The prognosis of dilated cardiomyopathy due to hypertension (HT-DCM) is surprisingly unknown, particularly in the absence of coronary disease and diabetes. We aimed at investigating the long-term outcome and the predictors of mortality in patients with left ventricular systolic dysfunction exclusively due to hypertension. From October 1995 to May 2001, 90 consecutive patients with echocardiographic fractional shortening (FS) <30% and 29 control patients with FS ⩾30% were included. Obstructive coronary disease was excluded by dipyridamole myocardial perfusion imaging in all patients and coronary angiography in 60. After a mean follow-up of 4.3±1.6 years, the total mortality rate of HT-DCM was twice as much higher than that of patients without left ventricular systolic dysfunction (
P
=0.01). In HT-DCM, the 5-year mortality rate was 26%. Univariate analyses selected age and creatinine for being positively related to mortality, and body mass index, FS and blood pressure during follow-up for being negatively related to mortality. Neither the improvement of left ventricular FS nor the decrease in left ventricular mass index was related to survival. Multivariate analysis identified (hazard ratio; 95% confidence interval) age (1.08; 1.02–1.13), body mass index (0.86; 0.75–0.98), and baseline FS (0.88; 0.78–0.98) as independent predictors of mortality. In conclusion, poor survival in HT-DCM can be anticipated by the severity of left ventricular systolic dysfunction and advanced age. Instead of ominous signs, high blood pressure and body mass may predict a more favourable prognosis.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>15716981</pmid><doi>10.1038/sj.jhh.1001836</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-9240 |
| ispartof | Journal of human hypertension, 2005-05, Vol.19 (5), p.393-400 |
| issn | 0950-9240 1476-5527 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67757812 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; SpringerLink Journals - AutoHoldings |
| subjects | Age Angiography Antihypertensive agents Arterial hypertension. Arterial hypotension Biological and medical sciences Blood and lymphatic vessels Blood pressure Blood Pressure - physiology Body Mass Index Cardiology. Vascular system Cardiomyopathy Cardiomyopathy, Dilated - etiology Cardiomyopathy, Dilated - mortality Cardiomyopathy, Dilated - physiopathology Cardiovascular system Care and treatment Clinical manifestations. Epidemiology. Investigative techniques. Etiology Coronary Angiography Creatinine Diabetes mellitus Diagnosis Dilated cardiomyopathy Dipyridamole Echocardiography Epidemiology Female Follow-Up Studies Health Administration Heart Heart diseases Heart Ventricles - diagnostic imaging Heart Ventricles - physiopathology Humans Hypertension Hypertension - complications Hypertension - diagnosis Hypertension - physiopathology Male Medical prognosis Medical sciences Medicine Medicine & Public Health Middle Aged Mortality Multivariate analysis Myocardial Contraction - physiology original-article Perfusion Pharmacology. Drug treatments Physiological aspects Predictive Value of Tests Prognosis Public Health Retrospective Studies Risk factors Severity of Illness Index Survival Rate - trends Time Factors Ventricle Ventricular Dysfunction, Left - complications Ventricular Dysfunction, Left - diagnosis Ventricular Dysfunction, Left - physiopathology |
| title | The long-term outcome of patients with hypertensive cardiomyopathy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T19%3A54%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20long-term%20outcome%20of%20patients%20with%20hypertensive%20cardiomyopathy&rft.jtitle=Journal%20of%20human%20hypertension&rft.au=de%20Carvalho%20Frimm,%20C&rft.date=2005-05-01&rft.volume=19&rft.issue=5&rft.spage=393&rft.epage=400&rft.pages=393-400&rft.issn=0950-9240&rft.eissn=1476-5527&rft_id=info:doi/10.1038/sj.jhh.1001836&rft_dat=%3Cgale_proqu%3EA183330769%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219966420&rft_id=info:pmid/15716981&rft_galeid=A183330769&rfr_iscdi=true |